Construction and Testing
From 2007.igem.org
(Difference between revisions)
(→Construction) |
(→Construction Tree) |
||
Line 2: | Line 2: | ||
The diagram below outlines our parallel construction plan, from individual registry parts to the final half-adder. Expected fragment sizes are shown at every node. | The diagram below outlines our parallel construction plan, from individual registry parts to the final half-adder. Expected fragment sizes are shown at every node. | ||
[[Image:UW_Construction_Chart.jpg|thumb|500px|left|Construction Chart]] | [[Image:UW_Construction_Chart.jpg|thumb|500px|left|Construction Chart]] | ||
+ | Diagram details: | ||
+ | *Vector resistances are shown, with shades of blue representing ampicillin and shades of red representing kanamycin | ||
+ | * | ||
<br style="clear:both;"/> | <br style="clear:both;"/> | ||
Revision as of 12:26, 26 October 2007
Contents |
Construction Tree
The diagram below outlines our parallel construction plan, from individual registry parts to the final half-adder. Expected fragment sizes are shown at every node.
Diagram details:
- Vector resistances are shown, with shades of blue representing ampicillin and shades of red representing kanamycin
Testing Constructs
Making use of flurorescent proteins(GFP and RFP) as reporter genes - use of indicuble promoters to...
Comparing basal and induced expression levels for the quorum sensing promoters